Robert Cascella, Director at Neuronetics, Inc. (STIM), bought 70,000 shares at $0.88 ($58K) on 2024-08-15, disclosed to the SEC on 2024-08-16.
Open-market purchase of $58k STIM by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.79 | 35,000 | $28K | 47.3% |
| 2 | $0.88 | 35,000 | $31K | 52.7% |
| Total | $0.83 avg | 70,000 | $58K | 100% |
| Filing → |
| STIM | BUY | 2024-06-06 | $205K | — | Filing → |
| STIM | BUY | 2023-09-20 | $52K | — | Filing → |
| KRMD | BUY | 2023-08-17 | $50K | — | Filing → |